BioTech Health XSeptember 29, 2021 BioTech CEO InterviewsXontogeny CEO Chris Garabedian Exclusive Interview [September 2021] 5 minute read As we expand our coverage of the biotechnology sector with the latest biotech news, our team at BioTech… 0 Shares 0 0 0 0 0 0 0
Jak ThomsonSeptember 7, 2021 Biotech NewsMacroGenics Announces Failure in SOPHIA Study of MARGENZA for Metastatic Breast Cancer Patients 3 minute read Biopharma MacroGenics, Inc. (NASDAQ: MGNX) announced that the final overall survival (OS) analysis did not demonstrate a statistically… 0 Shares 0 0 0 0 0 0 0
BioTech Health XSeptember 7, 2021 Biotech NewsInfinity Pharmaceuticals Add 2 New Members to Board of Directors 3 minute read Clinical-stage biotech Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced the change of 2 new Board of Directors roles including… 0 Shares 0 0 0 0 0 0 0
Jak ThomsonSeptember 7, 2021 BioTech CEO InterviewsExclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future 10 minute read About Cel-Sci Corporation Cel-Sci Corporation is a publicly traded biotechnology business which develops, manufactures, and markets treatments focused… 0 Shares 0 0 0 0 0 0 0
BioTech Health XSeptember 3, 2021 Biotech NewsCapricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) 4 minute read Capricor Therapeutics Announces HOPE-2 Trial Data Presentation On September 2nd, Capricor Therapeutics (NASDAQ: CAPR) announced an upcoming company… 0 Shares 0 0 0 0 0 0 0